Consultant lobbyist
Brittany Barnes
- Meetings this Parliament
- 2
- Since Nov 2021
- 2
- Active registrations
- 1
Brittany Barnes's lobbying: the clients they represent and every meeting they've reported since November 2021.
← LobbyingConsultant lobbyist
Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
Share patient groups perspectives on drug pricing and access to medications/vaccines/clinical trials, specifically regulations and guidelines related to the Patented Medicine Prices Review Board, along with feedback on their policies and practices, and processes related to PMPRB.
Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
Ensure timely access to a comprehensive range of medicines, vaccines and related treatments and protect access to clinical trials, while helping to rebuild domestic capacities to develop and make drugs and vaccines.
Support input regarding the Pharmaceutical and Life Sciences Sector Task Force.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.